Pharma and the Feds: Key Government Activities and How They Affect the Biopharmaceutical Industry

This iDRD (Insight-based Data-Rich Deliverable) is part of the Health Care subscription. This 11-page report provides a brief look into how mHealth will transform patient care. Topics such as the mobile patient experience, key vendors,  |  more...

In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than  |  more...

Win US Reimbursement and Build Payer Relationships Global trends have pushed managed markets teams into a pivotal position in the US market, where reimbursement has never been more difficult. With concepts such as comparative  |  more...

The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to  |  more...

Executive Summary The report titled “The US Health Insurance Industry Outlook to 2015 – Promising Health Reforms to Stimulate Industry Growth” provides a comprehensive analysis on the Health Insurance market in the US covering various aspects  |  more...